Altasciences Featured Content

  1. Planning Your First-In-Human Trial 1/26/2023

    Gain insight into why a first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug.

  2. Planning Your First-In-Human Trial 1/26/2023

    Advancing your molecule to first-in-human (FIH) clinical trials is a major milestone. Check out this eBook for your roadmap to successfully conducting FIH studies.

  3. Cardiac Safety Assessment In Clinical Trials 1/26/2023

    Find out why electrocardiography (ECG) is an integral part of the new drug regulatory environment.

  4. Hybrid Medicines And 505(b)(2) NDA Approval Pathways 1/25/2023

    Like the Hybrid medicine authorization process in the EU, the 505(b)(2) NDA approval process in the USA applies to generic molecules that have a slight change from the reference medicine, and can use published data.

  5. The Global Challenge Of Metabolic Disorders 1/25/2023

    Metabolic disorders can take many forms, with obesity and diabetes being the most common. Scientific research in obesity focuses on learning more about the associations between dietary patterns and obesity development and its treatment.

  6. Key Considerations For Biosimilar Clinical Pharmacology Studies 1/25/2023

    Biosimilars are usually given the same indications as the originator drugs but with reduced development cost, which translates to a lower market price, making them more accessible and affordable to patients.

  7. Assessing Human Abuse Potential To Limit The Misuse And Abuse Of Prescription Drugs 1/25/2023

    Learn how the FDA has undertaken efforts to manage the misuse and abuse of prescription drugs, including opioid analgesics, through guidelines for understanding the abuse potential of new drugs.

  8. Revolutionizing Traditional Medicine With Cannabis-Based Medicinal Products 1/25/2023

    Read how the key to implementing the use of cannabinoids to treat pain or other conditions is in continued research to identify the ideal cannabinoid components and doses for different indications.

  9. Challenges Associated With Schedule 1 Therapeutic Development 1/25/2023

    Delve into how recent research on psychedelics and entactogens is beginning to demonstrate potential therapeutic effects of Schedule 1 drugs for various medical indications.